Ciobanu Antonela, Miron Ingrith, Tansanu I
Facultatea de Medicină, Universităţii de Medicină si Farmacie "Gr. T. Popa", Iaşi.
Rev Med Chir Soc Med Nat Iasi. 2012 Jan-Mar;116(1):56-61.
Brain stem tumors account for about 10-20% of childhood brain tumors. Peak incidence for these tumors occurs around age 6 to 7 years.
Despite their severity and poor prognosis, brain stem tumors remain an area of intense research with regard to their diagnosis and management.
In the interval 2003-2010, 8 children (4 girls and 4 boys) aged 2-13 years (mean age 6.82), diagnosed with brain stem tumors were followed up. Disease history, onset symptoms, complete physical, laboratory and imaging investigations, and individualized therapeutic approach have been reviewed. Family history was considered to be of particular clinical importance. Monitoring the disease progression was possible until the time of death (when it occurred in hospital) or by information provided by the family and family physician in cases where death occurred at patient's home.
Clinical signs and symptoms depend on tumor location, its aggressiveness, and patient's age. Progressive neurological deficits, signs and symptoms caused by increased intracranial pressure, visual disturbances, behavioral disorders, seizures, endocrine disruption, failure to thrive may occur in various combinations. In only 50% of our cases the tumor could be removed. Imaging proved highly suggestive for a brain stem tumor. Histopathological examination diagnosed one pilocytic astrocytoma (grade I), one fibrillary astrocytoma (grade II), one anaplastic astrocytoma (grade III), and one glioblastoma multiforme (grade IV). In the remaining 4 cases imaging was suggestive for glial tumors. Multimodal therapy was used in 2 patients, 7 received adjuvant chemotherapy, and in 1 case no therapy was administered because the tumor rapidly progressed to death. Seven of our patients died on an average of 6.28 months after the diagnosis (range 2 to 9 months). A family history of brain tumors in 2 of our cases supports the hypothesis of genetic factors involvement.
Brain stem tumors are still difficult to investigate, and the results on their long- and medium-term survival remain uncertain.
脑干肿瘤约占儿童脑肿瘤的10%-20%。这些肿瘤的发病高峰出现在6至7岁左右。
尽管脑干肿瘤病情严重且预后不佳,但在其诊断和治疗方面仍是深入研究的领域。
在2003年至2010年期间,对8名年龄在2至13岁(平均年龄6.82岁)、被诊断为脑干肿瘤的儿童进行了随访。回顾了疾病史、起病症状、全面的体格、实验室和影像学检查以及个体化治疗方法。家族史被认为具有特别重要的临床意义。在患者于医院死亡时能够监测疾病进展情况,而在患者在家中死亡的情况下,则通过家属和家庭医生提供的信息进行监测。
临床体征和症状取决于肿瘤位置、侵袭性以及患者年龄。可能会以各种组合出现进行性神经功能缺损、颅内压升高引起的体征和症状、视觉障碍、行为障碍、癫痫发作、内分泌紊乱、发育不良。在我们的病例中,只有50%的肿瘤能够被切除。影像学检查对脑干肿瘤具有高度提示性。组织病理学检查诊断出1例毛细胞型星形细胞瘤(I级)、1例纤维型星形细胞瘤(II级)、1例间变性星形细胞瘤(III级)和1例多形性胶质母细胞瘤(IV级)。在其余4例中,影像学检查提示为胶质肿瘤。2例患者采用了多模式治疗,7例接受了辅助化疗,1例未进行治疗,因为肿瘤迅速进展导致死亡。我们的7例患者在诊断后平均6.28个月死亡(范围为2至9个月)。我们其中2例患者有脑肿瘤家族史,这支持了遗传因素参与的假说。
脑干肿瘤的研究仍然困难,其长期和中期生存结果仍不确定。